Objective: To evaluate the results of the intensive phase of CDT, including clinical and demographic features, breast cancer and pre and post treatment characteristics of the response to treatment in patients with BCRL. Method: Total 30 patients were included in this study. This study had pre-treatment and post-treatment design and all the measurements were taken at baseline and the duration of the treatment is 6 days, a week for 4 weeks. The participant’s intervention has begun the day they visited the clinic. With each intervention session lasting for 45-60 minutes, the participant’s attended 6 sessions separated by a one-day break between each week, spread over a period of 4 weeks. Result: The mean age was 49.5±9.9 and BMI was 28.6 kg/m2. Tumor Involved in breast; 14 (46.6%) cases of right breast and 16 (53.4%) cases of left breast. T stage (Tumor size in the Breast) were seen 1(3.35%) in Tis, T1 (20mm) in 17 (56.7%), T2 (20-50mm) in 11 (36.6%). None of the patient had stage T4. Nodal involvement; 18 (60%) patients had N0 and 12 (40%) had N+ and metastasis was seen 30 (100%) in M0. After 4th week total reduced mean volume of affected arm was 196 mL, total 36.6 % of reduction in the lymphedema volume Conclusion: Significant difference (p<0.0001) was seen in the mean volume of affected arm (pre and post-treatment). And there was no significant difference (p<0.980) seen in the mean volume of the normal (pre-treatment and Post-treatment)